We observed a larger percentage of CD8+ NK cells in hypertensive than in non-hypertensive patients with COVID-19 in this study, a result that aligns with our previous finding that increased CD8+ NKG2A+ MFI during hospitalization is linked to an increased risk of COVID-19 progression in hypertensive patients [7]. The gene discussed is CD8A; the disease is COVID-19.